Fingerprint
Dive into the research topics of 'Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically